Warning: This profiles contains records that have been removed from public view per our opt-out policy.

Novalar Pharmaceuticals, Inc.

Archived Record San Diego, CA

Novalar Pharmaceuticals, Inc. Overview

Novalar Pharmaceuticals, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California and is no longer active. This corporate entity was filed approximately twenty-five years ago on Monday, September 11, 2000 as recorded in documents filed with California Secretary of State. It is important to note that this is a foreign filing. A foreign filing is when an existing corporate entity files in a state other than the one they originally filed in. This does not necessarily mean that they are from outside the United States. There are several officers known to have been associated with this organization at one point.

Name
Donna Janson 2 ~ Background Report ~	President CEO Director Director
Robert Stefanovich ~ Background Report ~	CFO Treasurer Secretary
John J. Savarese 2 ~ Background Report ~	Director
Lowell E. Sears 1 ~ Background Report ~	Director

Florida Department of State

Filing Type:	Foreign for Profit Corporation
Status:	Inactive
State:	Florida
State ID:	F09000003687
Date Filed:	Wednesday, September 16, 2009

Texas Secretary of State

Filing Type:	Foreign For-Profit Corporation
Status:	Inactive
State:	Texas
State ID:	800989745
Date Filed:	Monday, June 9, 2008

California Secretary of State

Filing Type:	Statement & Designation By Foreign Corporation
Status:	Inactive
State:	California
Foreign State:	Delaware
State ID:	02261122
Date Filed:	Monday, September 11, 2000

Nevada Secretary of State

Filing Type:	Foreign Corporation
Status:	Inactive Withdrawn
State:	Nevada
Foreign State:	Delaware
State ID:	E0507152009-2
Date Filed:	Tuesday, September 22, 2009
Date Expired:	Thursday, September 15, 2011

Corporate Notes

Date	Type	Note
9/22/2009	Foreign Qualification	Initial Stock Value: Par Value Shares: 18,000,000 Value: $ 0.001 Par Value Shares: 13,149,907 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 31,149.91
9/22/2009	Initial List
9/22/2009	Miscellaneous
11/15/2010	Annual List
9/15/2011	Withdrawal

Trademarks for Novalar Pharmaceuticals, Inc.

	Novalar Serial Number: 78597422 Drawing Code: 4000
	Novalar Pharmaceuticals, Inc. Serial Number: 78597429 Drawing Code: 3000
	Novalar Serial Number: 77756424 Drawing Code: 3000
	Novalar Pharmaceuticals, Inc. Serial Number: 78597424 Drawing Code: 4000
	Zylara Serial Number: 78316849 Drawing Code: 1000